Ledger.Open graph →
SEC Form D · filed January 11, 2021

BlossomHill Therapeutics, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Li P. Yishan · San Diego, CAExec · DirectorJingrong P. Jean Cui · San Diego, CAExec · DirectorNiraj Ranjan · San Jose, CAExec · DirectorRajesh Raju · San Jose, CAExec · DirectorMatthew A. Jones · Powell, OHExec · DirectorMatthew Butcher · Longmont, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗